Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery
type: MedicalStudy
description: Protocol of Herceptin Adjuvant With Reduced Exposure, a Randomised Comparison of 6 Months vs 12 Months in All Women Receiving Adjuvant Herceptin [PHARE]
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2006-05
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00381901
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: National Cancer Institute, France
study subject: Breast Cancer
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Breast Cancer

AI Analytics
type: Organization